Patents by Inventor David D. L. Woo

David D. L. Woo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of cystic disease with compounds which stimulate TNF-.alpha. production in vivo
    Patent number: 6011055
    Abstract: A method for treating polycystic kidney disease in an individual in need thereof. This method includes identifying a mammal having a cystic disease and administering to the mammal a pharmacologically effective anti-cystic amount of TNF-.alpha. or an agent which stimulates TNF-.alpha. production in vivo. The agent is administered in a pharmacologically acceptable carrier, excipient or diluent.
    Type: Grant
    Filed: March 13, 1998
    Date of Patent: January 4, 2000
    Assignee: The Regents of the University of California
    Inventor: David D.L. Woo
  • Inhibition of cyst formation by cytoskeletal specific drugs
    Patent number: 5882881
    Abstract: The invention provides a method of producing a culture of polycystic kidney cells which form cysts in vitro. A cell culture of polycystic kidney cells is also provided. A method for screening an agent in vitro to determine the effectiveness of the agent in treating polycystic kidney disease is disclosed. Further, a method of treating a mammal having polycystic kidney disease by administering a pharmaceutical composition is provided.
    Type: Grant
    Filed: January 9, 1998
    Date of Patent: March 16, 1999
    Assignee: The Regents of the University of California
    Inventor: David D. L. Woo
  • Inhibition of cyst formation by cytoskeletal specific drugs
    Patent number: 5789189
    Abstract: The invention provides a method of producing a culture of polycystic kidney cells which form cysts in vitro. A cell culture of polycystic kidney cells is also provided. A method for screening an agent in vitro to determine the effectiveness of the agent in treating polycystic kidney disease is disclosed. Further, a method of treating a mammal having polycystic kidney disease by administering a pharmaceutical composition is provided.
    Type: Grant
    Filed: May 22, 1995
    Date of Patent: August 4, 1998
    Assignee: The Regents of the University of California
    Inventor: David D. L. Woo
  • Treatment of cystic disease with TNF-.alpha.
    Patent number: 5750495
    Abstract: A method for treating polycystic kidney disease in an individual in need thereof. This method includes identifying a mammal having a cystic disease and administering to the mammal a pharmacologically effective anti-cystic amount of TNF-.alpha. or an agent which stimulates TNF-.alpha. production in vivo. The agent is administered in a pharmacologically acceptable carrier, excipient or diluent.
    Type: Grant
    Filed: March 26, 1996
    Date of Patent: May 12, 1998
    Assignee: The Regents of the University of California
    Inventor: David D. L. Woo